Adamas Pharmaceuticals (ADMS)
NASDAQ:ADMS

Adamas Pharmaceuticals Similar Stocks

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Acorda Therapeutics
$12.86M
-0.10
-76.74%
premium
premium
AbbVie
$269.94B
21.91
+37.13%
11Buy
6Hold
0Sell
Moderate Buy
$163.24
premium
premium
Merck & Company
$223.43B
15.81
+22.90%
7Buy
3Hold
0Sell
Moderate Buy
$97.40
premium
premium
H Lundbeck
$4.39B
20.76
-28.35%
premium
premium
Adamas Pharmaceuticals
$376.37M
-4.80
+84.72%
0Buy
7Hold
0Sell
Hold
$8.40
premium
premium
ACADIA Pharmaceuticals
$2.88B
-17.08
-14.94%
7Buy
9Hold
0Sell
Moderate Buy
$29.07
premium
premium

Performance Comparison

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis